SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $391.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $391.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $148.00K, a 50.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $78.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $158.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2026 was -$100.00K, a 133.90% decline from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2025 was $295.00K, a 1452.63% increase from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2024 was $19.00K, a 85.04% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2023 was $127.00K, a 81.30% decline from fiscal 2022.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $391.00K 10-Q · filed 2026-08-06 | $539.00K derived: sum of 2 quarters · filed 2026-08-06 | $617.00K derived: sum of 3 quarters · filed 2026-08-06 | $775.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $226.00K derived: sum of 2 quarters · filed 2026-06-16 | $384.00K derived: sum of 3 quarters · filed 2026-06-16 | -$100.00K 10-K · filed 2026-06-16 |
| 2025-12-31 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $236.00K derived: sum of 2 quarters · filed 2026-02-10 | -$248.00K 10-Q · filed 2026-02-10 | $48.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | $158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | -$326.00K 10-Q · filed 2025-11-04 | -$30.00K derived: sum of 3 quarters · filed 2026-08-06 | -$93.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$484.00K 10-Q · filed 2026-08-06 | -$188.00K derived: sum of 2 quarters · filed 2026-08-06 | -$251.00K derived: sum of 3 quarters · filed 2026-08-06 | -$375.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $233.00K derived: sum of 2 quarters · filed 2026-06-16 | $109.00K derived: sum of 3 quarters · filed 2026-06-16 | $295.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | -$187.00K derived: sum of 2 quarters · filed 2026-02-10 | -$1.00K 10-Q · filed 2026-02-10 | $244.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $62.00K 10-Q · filed 2025-11-04 | $307.00K derived: sum of 3 quarters · filed 2025-11-04 | $434.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $186.00K 10-Q · filed 2025-08-07 | $431.00K derived: sum of 2 quarters · filed 2025-08-07 | $558.00K derived: sum of 3 quarters · filed 2025-08-07 | $25.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $372.00K derived: sum of 2 quarters · filed 2025-06-17 | -$161.00K derived: sum of 3 quarters · filed 2025-06-17 | $19.00K 10-K · filed 2025-06-17 |
| 2023-12-31 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | -$406.00K derived: sum of 2 quarters · filed 2025-02-05 | -$226.00K 10-Q · filed 2025-02-05 | -$445.00K derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | -$533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$353.00K 10-Q · filed 2024-11-07 | -$572.00K derived: sum of 3 quarters · filed 2024-11-07 | -$182.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $180.00K 10-Q · filed 2024-08-08 | -$39.00K derived: sum of 2 quarters · filed 2024-08-08 | $351.00K derived: sum of 3 quarters · filed 2024-08-08 | $193.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $171.00K derived: sum of 2 quarters · filed 2024-06-17 | $13.00K derived: sum of 3 quarters · filed 2024-06-17 | $127.00K 10-K · filed 2024-06-17 |
| 2022-12-31 | $390.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $232.00K derived: sum of 2 quarters · filed 2024-02-08 | $346.00K 10-Q · filed 2024-02-08 | $888.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$158.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$44.00K 10-Q · filed 2023-11-13 | $498.00K derived: sum of 3 quarters · filed 2023-11-13 | $804.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $114.00K 10-Q · filed 2023-08-10 | $656.00K derived: sum of 2 quarters · filed 2023-08-10 | $962.00K derived: sum of 3 quarters · filed 2023-08-10 | $753.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | $848.00K derived: sum of 2 quarters · filed 2023-06-21 | $639.00K derived: sum of 3 quarters · filed 2023-06-21 | $679.00K 10-K · filed 2023-06-21 |
| 2021-12-31 | $306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $97.00K derived: sum of 2 quarters · filed 2023-02-14 | $137.00K 10-Q · filed 2023-02-14 | $248.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | -$209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | -$169.00K 10-Q · filed 2022-11-14 | -$58.00K derived: sum of 3 quarters · filed 2022-11-14 | $23.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $40.00K 10-Q · filed 2022-08-11 | $151.00K derived: sum of 2 quarters · filed 2022-08-11 | $232.00K derived: sum of 3 quarters · filed 2022-08-11 | $319.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | $192.00K derived: sum of 2 quarters · filed 2022-07-13 | $279.00K derived: sum of 3 quarters · filed 2022-07-13 | -$668.00K 10-K · filed 2022-07-13 |
| 2020-12-31 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11 | $168.00K derived: sum of 2 quarters · filed 2022-02-11 | -$779.00K 10-Q · filed 2022-02-11 | |
| 2020-09-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | -$860.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$947.00K 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $330.00K 10-K · filed 2021-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |